Price Alert

Sanofi (SNY)

NASDAQ: SNY · Real-Time Price · USD

49.77

0.73 (1.49%)

At close: Aug 15, 2025, 3:59 PM

49.75

-0.05%

After-hours: Aug 15, 2025, 07:35 PM EDT

Sanofi Income Statement

Financials in EUR. Fiscal year is January - December.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Revenue	10.73B	10.61B	7.63B	14.16B	11.38B	11.12B	22.88B	12.7B	10.68B	10.86B	11.46B	13.14B	10.74B	10.05B	10.41B	10.83B	9.04B	8.89B
Cost of Revenue	2.99B	2.89B	2.27B	4.08B	3.39B	3.44B	8.2B	3.84B	3.27B	3.08B	3.73B	3.83B	3.25B	2.88B	3.47B	3.24B	2.86B	2.68B
Gross Profit	7.74B	7.72B	5.36B	10.07B	7.99B	7.68B	14.68B	8.86B	7.41B	7.78B	7.72B	9.31B	7.49B	7.17B	6.94B	7.59B	6.19B	6.2B
Operating Income	1.47B	2.29B	573M	3.63B	1.63B	2.03B	5.64B	3.21B	1.86B	4.14B	3.47B	5.84B	3.48B	3.7B	2.92B	4.31B	3.05B	3.38B
Interest Income	76M	86M	191.6M	133M	56M	102M	330M	143M	125M	161M	155M	52M	24M	10M	10M	2M	16M	14M
Pretax Income	1.42B	2.16B	456M	3.5B	1.42B	1.31B	2.92B	3.04B	1.78B	2.47B	4.08B	2.68B	1.38B	2.35B	1.41B	2.95B	1.48B	1.98B
Net Income	3.94B	1.87B	499M	2.81B	1.11B	1.13B	-555M	2.52B	1.44B	2B	3.11B	2.08B	1.18B	2.01B	1.13B	2.32B	1.21B	1.57B
Selling & General & Admin	2.63B	2.22B	1.24B	2.68B	2.69B	2.6B	5.51B	2.58B	2.58B	2.61B	2.94B	2.64B	2.6B	2.38B	2.8B	2.27B	2.36B	2.19B
Research & Development	1.91B	1.81B	2.12B	1.85B	1.72B	1.72B	3.54B	1.66B	1.63B	1.56B	1.82B	1.74B	1.72B	1.49B	1.59B	1.44B	1.4B	1.27B
Other Expenses	1.73B	1.4B	1.43B	1.9B	1.98B	n/a	n/a	n/a	n/a	793M	590M	280M	892M	714M	731M	674M	562M	490M
Operating Expenses	6.27B	5.43B	4.79B	6.44B	6.63B	6.27B	9.04B	5.4B	5.25B	4.96B	5.36B	4.66B	5.22B	4.58B	5.12B	4.38B	4.32B	3.95B
Interest Expense	87M	213M	312.84M	265M	135M	253M	1.08B	318M	202M	168M	180M	103M	101M	88M	127M	87M	112M	99M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	9.26B	8.32B	7.06B	10.52B	10.02B	9.71B	17.25B	9.24B	8.52B	-2.23B	99M	-2.75B	-2.78B	-1.87B	-1.95B	-1.32B	-1.75B	-1.45B
Income Tax Expense	230M	481M	4M	737M	299M	164M	872M	563M	271M	459M	910M	601M	163M	332M	267M	609M	274M	404M
Shares Outstanding (Basic)	2.47B	2.47B	2.51B	2.51B	2.5B	2.5B	2.51B	2.51B	2.5B	2.5B	2.51B	2.51B	2.5B	2.5B	2.51B	2.51B	2.5B	2.5B
Shares Outstanding (Diluted)	2.47B	2.47B	2.51B	2.51B	2.5B	2.5B	2.51B	2.51B	2.5B	2.5B	2.51B	2.51B	2.5B	2.5B	2.51B	2.51B	2.5B	2.5B
EPS (Basic)	1.60	0.76	0.27	1.13	0.45	0.46	-0.22	1.00	0.57	0.80	0.58	0.83	0.47	0.81	0.45	0.93	0.49	0.63
EPS (Diluted)	1.60	0.76	0.27	1.13	0.45	0.46	-0.22	1.00	0.57	0.80	0.58	0.83	0.47	0.81	0.45	0.93	0.49	0.63
EBITDA	1.89B	2.77B	563M	4.25B	2.51B	2.86B	1.64B	3.92B	6.33B	3.58B	2.42B	5.32B	5.68B	3.24B	1.91B	3.92B	2.46B	2.97B
EBIT	1.51B	2.37B	354M	3.77B	1.63B	2.03B	3.21B	3.35B	4.47B	2.82B	1.66B	4.65B	3.85B	2.57B	1.24B	3.2B	1.69B	2.25B
Depreciation & Amortization	378M	399M	209M	479M	882M	829.5M	2.99B	562M	1.86B	489M	1.61B	460M	1.83B	449M	1.63B	385M	1.73B	389M